Q-Line Biotech Limited
Share Price Target & Analysis
NSE:QLINE
VWAP
Open
Close
High
Low
52 Week High
-28.60 (-4.18%)
QLINE
(HEALTHCARE SERVICES)Sideways to Positive
52 Week Low
EPS
PE
PB
Standard
Quality
Bronze
Valuation
#Analysis
NSE: QLINE Share Price Financial Analysis & Valuation
Q-Line Biotech Limited (QLINE) is broadly categorized in HEALTHCARE SERVICES segment industry which deals in Medical Equipment/Supplies/Accessories vertical.
It is one of Micro Cap company with Market Capitalization of Rs 0 (in Cr). Total number of free float shares are 0 (in Lacs).
Q-Line Biotech Limited is listed on NSE with Exchange ID - INE1G2W01011 and trading code is NSE:QLINE with short name Q-Line Biotech.
In the past 1 year, Q-Line Biotech Limited has declared an equity dividend of Rs 0 per share. At the current share price of QLINE at Rs 655.75, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:QLINE, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine QLINE underlying value and future prospects. All of this data is available in QLINE financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:QLINE, it is clearly understood that QLINE is Standard performer in terms of earnings and profit margins with an EPS of 42.28. NSE:QLINE book value per share as of today is 70.42. The current price to book ratio for QLINE as of Oct 09, 2026 is 9.31.
Valuation of the Stock: The current valuation of QLINE stock is like Bronze which means currently the stock is Reasonably Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of QLINE whether to BUY this stock at current valuation. The delivery percentage of QLINE is 30800% is very crucial parameter which shows that 30800% investors are anticipating that the price of QLINE share should go up with VWAP at 666.98.
Now, the main question is whether to BUY or SELL, NSE:QLINE at current valuation.
As per latest Analysis No. #197:-
⇑ STRONG BUY QLINE if All Greens
⇗ BUY QLINE (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD QLINE (With Stop Loss) if only 1 Green
⇘ SELL QLINE if NO Green Indicator
NSE: QLINE Share Price Today (Oct 09, 2026)
(Q-Line Biotech Limited Daily Analysis on the basis of QLINE Intraday Graph & Trend)
Q-Line Biotech Limited share price moved Down by -4.18% from its previous close of Rs 684.35. QLINE stock last traded price is 655.75. QLINE share price trend is Down with a total of 90000 stocks traded till now. It has touched an intraday high of Rs 683.95 and an intraday low of Rs 650. The QLINE trading at 655.75, Down by Rs. -28.60, or -4.18 percent which suggests that most of the Traders are anticipating that the price of QLINE share should go Down.
NSE: QLINE Share Price Tomorrow Prediction
(Q-Line Biotech Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of QLINE)
Q-Line Biotech Limited share price moved Down by -4.18%. QLINE share price short term trend is Down. It suggests that QLINE Share Price for Tomorrow remains the same with VWAP at 666.98 will be treated as stop loss for intraday traders. Q-Line Biotech Limited Long term investors can follow the QLINE long term trend as mentiond in future forecast table.
NSE Code |
NSE: QLINE |
QLINE Share Price Today |
655.75 |
QLINE Share Price Target Prediction for 2026 ^ |
560.6 - 738.6 |
QLINE Share Price Target Prediction for 2027*^ |
738.6 - 786.9 |
QLINE Share Price Target Prediction for 2028*^ |
786.9 - 842 |
QLINE Share Price Target Prediction for 2029*^ |
884 |
QLINE Share Price Target Prediction for 2030*^ |
909 |
QLINE Share Price Target Prediction for 2035*^ |
991 |
| QLINE Current Book Value |
70.1 |
*Q-Line Biotech Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^QLINE share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
QLINE Technical Analysis (In Process... .. .)
Please wait a moment or refresh the page to check again.
(powered by Zerodha)
Most popular Questions & Answers about QLINE
Q-Line Biotech Limited Frequently Asked Questions (FAQs)Q-Line Biotech Limited stock last traded price is 655.75. QLINE share price moved Down by -4.18% from its previous close of Rs 684.35.
Q-Line Biotech Limited share price trend is Down with a total of 90000 stocks traded till now. It has touched an intraday high of Rs 742.35 and an intraday low of Rs 650. The QLINE trading at 655.75, Down by Rs. -28.60, or -4.18 percent which suggests that most of the Traders are anticipating that the price of QLINE share should go Down and the Stop Loss will be around 666.98.
The market cap of Q-Line Biotech Limited is ₹0 (in Cr) as of Oct 08, 2026.
The current price to earning ratio for Q-Line Biotech Limited as of Oct 08, 2026 is 26.86.
The current price to book ratio for Q-Line Biotech Limited as of Oct 08, 2026 is 9.31.
The highest price of Q-Line Biotech Limited stock is ₹735 in the last 52-week.
The lowest price of Q-Line Biotech Limited stock is ₹431 in the last 52-week.
Q-Line Biotech Limited share trading at ₹655.75, Down by Rs. -28.60, or -4.18 percent which suggests that most of the traders are anticipating that the price of QLINE share should go Down.
In 2026, Stock price target for Q-Line Biotech Limited (QLINE) will be around ₹560.6 on downside and ₹738.6 on upside. Q-Line Biotech Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Q-Line Biotech Limited (QLINE) will be around ₹738.6 on downside and ₹786.9 on upside. Q-Line Biotech Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Q-Line Biotech Limited (QLINE) will be around ₹786.9 on downside and ₹842 on upside. Q-Line Biotech Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Q-Line Biotech Limited (QLINE) will be around ₹909 Q-Line Biotech Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of QLINE.
The price of Q-Line Biotech Limited (QLINE) shares moved by -4.18%. The short-term trend for QLINE share price is Down. It implies that the share price of QLINE will stay the same tomorrow and that intraday traders should treat VWAP at 666.98 as a stop loss. Investors with a long-term outlook can track QLINE long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of QLINE stock is 506.9. Compared to the current market price of 655.75 INR, the QLINE stock is Overvalued by 22.7%.
As per the fundamental analysis of Q-Line Biotech Limited (QLINE), it is of Standard quality in terms of earnings and profit margins with an EPS of 42.28. Q-Line Biotech Limited book value per share as of today is 70.42. The current price to book ratio for QLINE as of Oct 09, 2026 is 9.31.
NSE:QLINE News & Other Useful Information about QLINE Share Price
Peer Comparison of NSE: QLINE
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Medical Equipment/Supplies/Accessories
| Company | Price | EPS | BV |
|---|---|---|---|
| NURECA | 331.35 | 2.17 | 180.05 |
| QMSMEDI | 192.52 | 5.43 | 55.28 |
| HOLMARC | 122.00 | 5.52 | 30.69 |
| INDGN | 586.15 | 10.34 | 88.85 |
| AAKAAR | 66.00 | 5.09 | 38.49 |
| GML | 16.65 | 2.61 | 26.59 |
| QLINE | 655.75 | 42.28 | 70.42 |
| AVIENCE | 276.60 | 19.13 | 40.07 |
| MOLBIO | 1479.20 | 16 | 86.72 |
| PRAMODINI | 114.40 | 14.84 | 26.89 |